Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0ED6O
|
|||
| Drug Name |
CSTC1
|
|||
| Synonyms |
BAC; D-Bacillosamine; Bacillosamine; D-Bac; 2,4-Diamino-2,4,6-Trideoxy-D-Glucopyranose; 2,4-Diamino-2,4,6-Trideoxy-Glucose; 2,4,6-Trideoxy-2,4-Diamino-Glucose; 2,4-Diamino-2,4,6-Trideoxy-D-Glucose; 2,4,6-Trideoxy-2,4-Diamino-D-Glucose; 2,4,6-Trideoxy-2,4-Diamino-Glucopyranose; 2,4-Diamino-2,4,6-Trideoxy-Glucopyranose; 2,4-Diamino-2,4,6-Trideoxy-Glucopyranoside; 2,4,6-Trideoxy-2,4-Diamino-Glucopyranoside; 2,4,6-Trideoxy-2,4-Diamino-D-Glucopyranose; 2,4,6-Trideoxy-2,4-Diamino-D-Glucopyranoside; 2,4-Diamino-2,4,6-Trideoxy-D-Gluc
Click to Show/Hide
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 2 | [1], [2] | |
| Company |
Charsire Biotechnology Tainan, Taiwan
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C6H14N2O3
|
|||
| Canonical SMILES |
CC1C(C(C(C(O1)O)N)O)N
|
|||
| InChI |
1S/C6H14N2O3/c1-2-3(7)5(9)4(8)6(10)11-2/h2-6,9-10H,7-8H2,1H3/t2-,3-,4-,5+,6?/m1/s1
|
|||
| InChIKey |
LEJHBBPEPOZERQ-RSVSWTKNSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.